000 | 00985 a2200301 4500 | ||
---|---|---|---|
005 | 20250518053137.0 | ||
264 | 0 | _c20201022 | |
008 | 202010s 0 0 eng d | ||
022 | _a1664-3224 | ||
024 | 7 |
_a10.3389/fimmu.2019.01719 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXia, Anliang | |
245 | 0 | 0 |
_aT Cell Dysfunction in Cancer Immunity and Immunotherapy. _h[electronic resource] |
260 |
_bFrontiers in immunology _c2019 |
||
300 |
_a1719 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aNeoplasms _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
700 | 1 | _aZhang, Yan | |
700 | 1 | _aXu, Jiang | |
700 | 1 | _aYin, Tailang | |
700 | 1 | _aLu, Xiao-Jie | |
773 | 0 |
_tFrontiers in immunology _gvol. 10 _gp. 1719 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3389/fimmu.2019.01719 _zAvailable from publisher's website |
999 |
_c29973745 _d29973745 |